Skip to main content
ADVANCED MEDICAL SOLUTIONS GROUP PLC logo

ADVANCED MEDICAL SOLUTIONS GROUP PLC — Investor Relations & Filings

Ticker · AMS ISIN · GB0004536594 LEI · 213800HJP6OWOSZI1L74 IL Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2025-03-31 Regulatory Filings
Country GB United Kingdom
Listing IL AMS

About ADVANCED MEDICAL SOLUTIONS GROUP PLC

https://admedsol.com/

Advanced Medical Solutions Group plc is a world-leading independent developer and manufacturer of innovative tissue-healing technologies. The company operates through two primary divisions: Surgical and Woundcare. The Surgical portfolio includes a range of products such as tissue adhesives, sutures, haemostats, and internal fixation devices designed for tissue closure and sealing. The Woundcare division focuses on advanced products for managing acute and chronic wounds, utilizing high-performance natural and synthetic polymers. The company is dedicated to delivering high-quality, innovative solutions that improve patient outcomes and provide value to clinicians and healthcare payors.

Recent filings

Filing Released Lang Actions
Total Voting Rights
Regulatory Filings Classification · 100% confidence The document is a standard regulatory announcement regarding 'Total Voting Rights' issued in accordance with the FCA's Disclosure and Transparency Rule 5.6.1. It provides the total number of shares and voting rights to assist shareholders with regulatory notifications. As this is a standard regulatory disclosure that does not fit into specific categories like dividends, M&A, or financial reports, it is classified as a Regulatory Filing (RNS).
2025-03-31 English
Directorate Change
Board/Management Information Classification · 100% confidence The document is an official announcement from Advanced Medical Solutions Group plc regarding a 'Directorate Change', specifically the appointment of a new Independent Non-Executive Director, Susan Searle. It details her background, committee assignments, and required regulatory disclosures under AIM Rules. This fits the definition of a management/board change announcement.
2025-03-31 English
Response to Statement re Possible Offer
M&A Activity Classification · 100% confidence The document is an official announcement regarding a potential takeover bid (Montagu Private Equity LLP's interest in Advanced Medical Solutions Group plc). It explicitly references the 'City Code on Takeovers and Mergers' and 'Rule 2.4', which are standard regulatory requirements for M&A activity announcements. As it details a potential offer and the initiation of an 'offer period', it falls squarely under the M&A Activity category.
2025-03-27 English
Unaudited Preliminary Results
Earnings Release Classification · 99% confidence The document is titled "Unaudited preliminary results for the year ended 31 December 2024" and contains a detailed financial summary comparing 2024 results to 2023, including revenue, EBITDA, profit before tax, EPS, and proposed dividends. It also includes operational highlights, management commentary, and detailed segment breakdowns. This structure is characteristic of a company releasing its full-year financial performance summary. Since it covers the full fiscal year and provides comprehensive financial details, it aligns best with the definition of an Annual Report (10-K) or, more commonly for preliminary releases outside the US SEC system, a comprehensive Annual Report/Results Announcement. Given the options, and the fact that it is a comprehensive summary of the full year's performance, it is classified as an Annual Report (10-K) or, if it were a preliminary release, it would often be accompanied by an Earnings Release (ER) or Interim Report (IR). However, because it presents the full year's audited/unaudited results comprehensively, it is closest to the 10-K scope, though often these preliminary results are released via RNS/ER first. Since this document contains the full financial tables and narrative for the year ended 31 December 2024, it functions as the primary annual financial disclosure. Given the context of UK/AIM reporting, this is the equivalent of the full annual results announcement, which often precedes the formal 10-K filing if the company is dual-listed or follows US standards. Since it is a comprehensive annual result disclosure, and not just a short announcement of results, it is classified as 10-K, which covers the official yearly report covering company activity and full financial performance. FY 2024
2025-03-19 English
Directorate Change
Board/Management Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number: 0218B) on March 18, 2025, titled 'Directorate Change'. It explicitly details the resignation of the Chair (Liz Shanahan) and the appointment of a new Non-Executive Chair (Grahame Cook). This content directly matches the definition for Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-03-18 English
Block listing Interim Review
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and contains a notification pursuant to 'Schedule Six of the AIM Rules for Companies'. The content details the balance and movement of securities under various employee share schemes (Deferred Share Bonus Scheme, EMI Scheme, etc.) over a specific period (6 September 2024 to 5 March 2025). This type of filing, which reports on the status of listed securities or compliance with exchange rules but doesn't fit neatly into core financial reports (10-K, IR, ER), is best classified as a general Regulatory Filing (RNS). Although it relates to capital/shares, it is a compliance report about existing schemes rather than a primary announcement of a new share issue (SHA) or buyback (POS). Given the RNS source and the nature of the compliance update, RNS is the most appropriate general category.
2025-03-14 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.